RecruitingNot ApplicableNCT05091255

Cryotherapy in the Treatment of Desmoid Tumors


Sponsor

Istituto Ortopedico Rizzoli

Enrollment

94 participants

Start Date

May 20, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

Desmoid tumor is a benign neoplasm with an unpredictable course and a high rate of local recurrence if treated surgically. Therefore, over time the surgical approach has become conservative, preferring simple observation or medical therapy in case of disease progression through the use of hormonal therapy and low-dose chemotherapy. Since this neoplasm remains benign, our study aims to avoid chemotherapy in patients usually young through the use of a minimally invasive treatment such as cryotherapy.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • histologic diagnosis of desmoid tumors
  • age > 18 years
  • abdominal and extra-abdominal desmoid tumors

Exclusion Criteria3

  • contraindication to the procedure by the interventional radiologist in terms of tumor proximity to neurologic/vascular structures
  • retroperitoneal desmoid tumors
  • age < 18 years

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURECryotherapy

The procedure involves general or peripheral anesthesia and percutaneous treatment under CT control with probes capable of forming ice spheres of up to 3 cm that will be used in sufficient number to treat the neoplasm completely.


Locations(1)

IRCCS Itituto Ortopedico Rizzoli

Bologna, BO, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05091255


Related Trials